SCHEMBL22160166

SCHEMBL22160166

O=C(CCc1c(-c2ccc(F)cc2)[nH]c2c(F)cc(F)cc12)NC1CCNC1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APOL1 O14791 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22160216 1.00 APOL1 (1.00) APOL1
SCHEMBL22118385 1.00 APOL1 (1.00) APOL1
SCHEMBL24099214 0.94 APOL1 (0.90) APOL1
SCHEMBL24099480 0.94 APOL1 (0.90) APOL1
SCHEMBL24907088 0.94 APOL1 (0.90) APOL1
SCHEMBL22161322 0.94 APOL1 (0.88) APOL1
SCHEMBL22160037 0.94 APOL1 (0.88) APOL1
SCHEMBL22159837 0.94 APOL1 (0.88) APOL1
SCHEMBL22161403 0.93 APOL1 (0.86) APOL1
SCHEMBL22118330 0.92 APOL1 (0.85) APOL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020131807-A1 INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2020-06-25 WO disclosed